MFGM
VRTX icon

Marshall Financial Group (Maryland)’s Vertex Pharmaceuticals VRTX Stock Holding History

Marshall Financial Group (Maryland)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-512
Closed -$235K – 267
2025
Q2 		$235K Sell
512
-136
-21% -$62.7K 0.05% 233
2025
Q1 		$314K Sell
648
-312
-33% -$145K 0.07% 190
2024
Q4 		$387K Sell
960
-3,963
-80% -$1.84M 0.09% 159
2024
Q3 		$2.29M Sell
4,923
-88
-2% -$42.3K 0.55% 43
2024
Q2 		$2.35M Buy
5,011
+176
+4% +$76.4K 0.66% 38
2024
Q1 		$2.02M Buy
4,835
+168
+4% +$71K 0.58% 44
2023
Q4 		$1.9M Sell
4,667
-55
-1% -$20.3K 0.61% 44
2023
Q3 		$1.64M Buy
4,722
+39
+0.8% +$13.6K 0.59% 49
2023
Q2 		$1.65M Buy
4,683
+132
+3% +$44.5K 0.56% 49
2023
Q1 		$1.43M Buy
4,551
+79
+2% +$23.7K 0.51% 52
2022
Q4 		$1.29M Buy
+4,472
New +$1.36M 0.5% 63

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Marshall Financial Group (Maryland)'s VRTX Position: Q3 2025 in Review

Marshall Financial Group (Maryland) sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 512 shares — an estimated $235K sold.

Marshall Financial Group (Maryland) first reported a position in VRTX in Q4 2022 and held it in 11 quarters. The position peaked at $2.35M in Q2 2024. 1,520 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Marshall Financial Group (Maryland) reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Marshall Financial Group (Maryland) sold 512 Vertex Pharmaceuticals shares in Q3 2025, an estimated $235K.
  • Marshall Financial Group (Maryland) first reported a position in Vertex Pharmaceuticals in Q4 2022 and held it in 11 quarters.
  • Marshall Financial Group (Maryland)'s Vertex Pharmaceuticals position peaked at $2.35M in Q2 2024.
  • 1,520 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q3 2025, filed 8 Oct 2025.